← Back to Search

Retrieval Practice Strategies for Language Learning in Deaf and Hard of Hearing Children

N/A
Recruiting
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English is only spoken language
Be younger than 18 years old
Must not have
Evidence of severe motor impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of intervention. the intervention ends when the participant achieves >75% accuracy 3 sessions in a row (up to 6 months).
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how feedback and spacing can help 4 kids learn and remember words better.

Who is the study for?
This trial is for deaf and hard of hearing children aged 5-8 who only speak English, have some prelingual hearing loss, and normal nonverbal cognition. They should have basic receptive and expressive vocabulary skills but can't participate if they have severe motor impairments or uncorrected vision issues.
What is being tested?
The study tests how well different teaching methods help these children learn words. It compares giving feedback versus no feedback, and doing learning sessions close together (massed) versus spread out over time (spaced). There's also a control group with no teaching.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no physical side effects expected. However, participants may experience varying levels of stress or frustration depending on the effectiveness of the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I only speak English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe difficulty moving or controlling my movements.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of intervention. the intervention ends when the participant achieves >75% accuracy 3 sessions in a row (up to 6 months).
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of intervention. the intervention ends when the participant achieves >75% accuracy 3 sessions in a row (up to 6 months). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Labeling - acquisition
Labeling - retention
Secondary study objectives
Identifying - acquisition
Identifying - retention
Semantic - acquisition
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Contrast DExperimental Treatment3 Interventions
Spaced vs massed trials with feedback
Group II: Contrast CExperimental Treatment3 Interventions
Spaced vs massed trials without feedback
Group III: Contrast BExperimental Treatment3 Interventions
Feedback vs no feedback with spaced trials
Group IV: Contrast AExperimental Treatment3 Interventions
Feedback vs no feedback with massed trials

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
901 Previous Clinical Trials
939,610 Total Patients Enrolled

Media Library

Contrast B Clinical Trial Eligibility Overview. Trial Name: NCT05512000 — N/A
Neonatal Hearing Loss Research Study Groups: Contrast B, Contrast C, Contrast D, Contrast A
Neonatal Hearing Loss Clinical Trial 2023: Contrast B Highlights & Side Effects. Trial Name: NCT05512000 — N/A
Contrast B 2023 Treatment Timeline for Medical Study. Trial Name: NCT05512000 — N/A
~0 spots leftby Dec 2024